Mangoceuticals, Inc.

🚀 Our team’s dedication and innovative spirit continue to drive our success. Excited for what’s next! #Growth #Innovation #TeamSuccess” Check out our latest reporting news here: https://lnkd.in/gBTB2icT

We are thrilled to announce that MangoRx has secured DEA approval for our HIPAA-compliant operating system via Surescripts, placing us at the forefront of the direct-to-consumer telemedicine market. This milestone allows our provider networks to prescribe a comprehensive range of controlled medications, including hormone replacement therapies, enabling physicians to have greater flexibility in prescribing custom treatments tailored to meet patient's needs. “Our system is now capable of supporting hyper-growth and has the limitless ability to add new and innovative products,” says Amanda Hammer, Chief Operating Officer of MangoRx.“This ensures that we remain at the cutting edge of the telemedicine industry, delivering exceptional value to our patients and stakeholders while maintaining security and regulatory compliance." Jacob Cohen, Co-Founder and CEO added, “We anticipate exponential growth in our subscriber base with the launch of MangoRx's new operating system.” Read more here: https://lnkd.in/gWwuGCgK #MangoRx #HealthcareInnovation #HealthcareTechonolgy

We've received a Notice of Allowance for our patent application in Japan, which is a major step forward in our global strategy to revolutionize preventive care. 🌏 This patent covers our groundbreaking technology acquired from IntraMont Technologies, Inc., designed to prevent respiratory and oral infections through innovative solutions like toothpaste and lozenges. Jacob Cohen, Co-Founder and CEO, says, "This achievement underscores our commitment to delivering advanced preventive care to new markets." We're excited to bring our cutting-edge products to Japan and beyond! 🚀 #HealthcareInnovation #PreventiveCare #MangoRx #GlobalExpansion Read the article here: https://lnkd.in/gUYz-sup

We are thrilled to announce the development of Mojo by MangoRx, an innovative Oral Dissolvable Tablet (ODT) aimed at restoring hormonal balance and naturally increasing testosterone levels in men. Mojo features a unique blend of Enclomiphene Citrate, Pregnenolone, and DHEA, making it a powerful alternative to traditional Testosterone Replacement Therapy (TRT).   💡 Key Benefits of Mojo by MangoRx: - Stimulates natural testosterone production - Supports overall hormonal balance and well-being - Enhances cognitive and mental health   Mojo will be available on our website exclusively on a subscription basis. This groundbreaking product is designed for younger men in the early stages of low testosterone, offering a safe and effective solution without compromising fertility.   As the market for male hormonal therapies continues to grow, we are proud to lead the way with Mojo by MangoRx, setting a new standard in male health and wellness. Learn More: https://lnkd.in/gEJtH4db #MangoRx #HealthcareInnovation #MensHealth #TestosteroneBooster #TRT #MojobyMangoRx

Mangoceuticals, Inc. is thrilled to announce the completion of our first batch of MangoRx ED oral dissolvable tablets (ODTs) for Mexico and Latin America! 🌎 Produced in partnership with Emifarma, these Tadalafil-based ODTs are set to undergo final testing to ensure top-notch quality. “This milestone marks our significant expansion into the Mexican and Latin American markets,” says Jacob Cohen, Co-Founder and CEO. We’re committed to meeting COFEPRIS standards and bringing our high-quality ED solutions to these new regions. Efi Karchmer, President of MangoRx Mexico, added, “Our collaboration with Emifarma has been instrumental in achieving this milestone. Their advanced facilities and proactive approach have enabled us to move forward swiftly and confidently. We are excited about the potential to scale our business and bring our innovative ED solutions to the Mexican market and beyond.” According to a recent market study and analysis report conducted by Groupo Knobloch, the annual market size in Mexico for ED pharmaceutical products is estimated at USD $216 million, with approximately 24 million units sold annually. Exciting times are ahead as we prepare for further production and certification to bring our innovative products to more markets beyond Mexico, including Colombia, Ecuador, El Salvador, Chile, Costa Rica, and Panama. Link to full article here: https://lnkd.in/g2mCHCY2 #Mangoceuticals #MangoRx #HealthcareInnovation #MenHealth #MexicoExpansion #Pharmaceuticals #LatinAmericaExpansion

We’re thrilled to announce our engagement and collaboration with Crakmedia, a global leader in performance marketing. Based in Quebec City, Crakmedia boasts over 1.5 billion daily ad views across 150+ countries and a top-notch CPA network. This partnership aims to amplify MangoRx's digital marketing strategies and affiliate programs, leveraging Crakmedia’s extensive expertise and award-winning track record. "Since launching its products in 2021, MangoRx has been meeting a very real need in the health and wellness industry and we're thrilled to partner with such an amazing and innovative brand," said Olivier Bouchard, COO at Crakmedia. "With our experience in efficiently marketing similar telemedicine services coupled with MangoRx's innovative formulas, products, and brand voice, we're confident that Crakmedia will enable MangoRx to take the next step in acquiring new customers and continuing its growth.”   Jacob Cohen, CEO of MangoRx, highlights Crakmedia's successful DTC marketing for men’s health as a significant advantage in our most recent press release found here: https://lnkd.in/gcWcAU3B Stay tuned for more exciting updates as MangoRx and Crakmedia take men’s health and wellness to new heights! 🚀 #StrategicPartnerships #MensHealth #DigitalMarketing #HealthcareInnovation

We're set to launch oral dissolvable tablets of Semaglutide ("Slim") and Tirzepatide ("Trim") for weight management. 💊 These innovative formulations, set to launch in Q3 2024, offer a convenient alternative to injections and are priced at $299/month and $399/month. With proven weight loss efficacy, "Slim" and "Trim" aim to revolutionize the weight loss market. 🌟 CEO and Co-Founder, Jacob Cohen added “Our goal is to provide patients with a convenient and effective way to manage their weight and improve their overall health. We believe that these oral formulations have the potential to significantly impact the lives of millions of people worldwide.” Read more here: https://lnkd.in/gYDdb_CX #Health #Wellness #WeightLoss #HealthcareInnovation #NasdaqNews #MangoRx

We are thrilled to announce that Mangoceuticals, Inc. has officially launched its direct-to-clinics sales division, revolutionizing the way doctors prescribe and patients access MangoRx products! This initiative allows medical practitioners to prescribe MangoRx products directly from their offices, clinics, and brick-and-mortar locations. Last week, we welcomed our first medical health and wellness clinic in Dallas, TX, marking the beginning of a transformative era in patient care. By introducing this innovative approach, MangoRx aims to drive greater recurring revenues while slashing customer acquisition costs associated with traditional marketing strategies. Unlike any other in our industry, we're deploying a dedicated sales force to reach men's health and wellness clinics nationwide, ensuring our products are readily available where they're needed most. Our Co-Founder and President, Jonathan Arango, highlighted the strategic significance of this move, stating, "This initiative has been in the works since the 4th quarter of 2023, driven by the overwhelming interest from doctors wanting to prescribe MangoRx products to their patients. Our custom-built prescribing system now empowers practitioners to seamlessly integrate MangoRx into their patient care." The introduction of our prescribing system signifies a pivotal shift, allowing doctors to initiate transactions for MangoRx products, previously only initiated by consumers. Furthermore, we're launching a dedicated website for providers to easily onboard and qualify as MangoRx preferred providers. Jacob Cohen, our Co-Founder and CEO, emphasized the tremendous growth potential of this initiative, stating, "With providers prescribing thousands of ED prescriptions annually, coupled with the opportunity to prescribe 'PRIME,' by MangoRx, powered by Kyzatrex®, we anticipate exponential revenue growth. We're confident this initiative will solidify MangoRx's position as a household name in the health and wellness industry." Exciting times lie ahead as MangoRx continues to innovate and redefine the healthcare landscape. Read more here: https://lnkd.in/gG4Fji3E #MangoRx #HealthcareInnovation #DirectToClinics #RevolutionizingWellness

In the aftermath of Sunday's Big Game loss, Mangoceuticals, Inc. is stepping up to ensure that the San Francisco 49ers and their loyal fans can still find reasons to celebrate. As a gesture of solidarity and support, we’ve announced that we'll be providing the San Francisco players and coaches with a free one-year supply of our uniquely formulated ED product, Mango by MangoRx. At MangoRx, we understand that disappointments on the field can sometimes carry over into other aspects of life. Our mission is to help men tackle these issues, and we believe that maintaining confidence and intimacy is essential, regardless of the outcome of a game. But the support doesn't stop there! We're extending our offer to the incredible fans who have stood by their team through thick and thin. By using the special discount code "SB58," fans can claim 3 FREE Mango pills, reflecting the game's point difference. Our signature ED product, Mango, is a carefully formulated solution designed to enhance performance and confidence in the bedroom. With a delicious mango flavor and rapid dissolve technology, it's both effective and convenient. Players and coaches are encouraged to reach out to [email protected] with the subject line "The Big Game" to redeem their offer or inquire further. In times of defeat, it's important to remember that support and camaraderie can make all the difference. We're proud to stand with the San Francisco team and their incredible fanbase, and we look forward to brighter days ahead. Read more here: https://lnkd.in/ecKKnKP9 #MangoRx #Superbowl58 #MangobyMangoRx #Menshealth

Mangoceuticals, Inc. announces its commitment to supporting teams facing defeat with a generous offer. Regardless of the Big Game outcome this Sunday 🏈, MangoRx will provide the losing team with a complimentary one-year supply of its signature ED product, Mango🥭. This initiative aims to uplift spirits and address the potential emotional toll of sporting losses on intimate health. In addition to this offer, fans will also benefit from special discounts, reflecting the game's point difference, and site-wide promotions. Dr. Douglas Christianson, ND, an advisory board member, highlights the correlation between emotional well-being and physical performance, emphasizing MangoRx's unique approach to men's health. MangoRx's ED product, formulated with Tadalafil or Sildenafil, combined with Oxytocin and L-Arginine, offers a unique formulation in a convenient, fast-acting mango-flavored tablet. Jacob Cohen, Co-Founder and CEO of MangoRx, underscores the company's dedication to helping individuals overcome life's challenges, both on and off the field. As part of its commitment to promoting men's health, MangoRx is proud to sponsor various programs during the Big Game week, including events with Barstool Sports in Las Vegas. Through strategic partnerships and outreach efforts, MangoRx aims to extend its impact and awareness to a wider audience. Read more here: https://lnkd.in/eKPwrAHR #MangoRx #HealthcareInnovation #MangobyMangoRx #BarstoolSports #Sports #Menshealth